Olink Proteomics Revenue and Competitors

Uppsala, Sweden

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Olink Proteomics's estimated annual revenue is currently $123.5M per year.(i)
  • Olink Proteomics's estimated revenue per employee is $155,000

Employee Data

  • Olink Proteomics has 797 Employees.(i)
  • Olink Proteomics grew their employee count by 8% last year.

Olink Proteomics's People

NameTitleEmail/Phone
1
Chief People OfficerReveal Email/Phone
2
COOReveal Email/Phone
3
CSOReveal Email/Phone
4
VP Global MarketingReveal Email/Phone
5
Head Global ITReveal Email/Phone
6
VP Sales and MarketingReveal Email/Phone
7
Head Financial Planning & AnalysisReveal Email/Phone
8
Head Commercial FinanceReveal Email/Phone
9
VP Global Strategic AccountsReveal Email/Phone
10
Head Analysis ServiceReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$123.5M7978%N/AN/A
#2
$22.2M1437%N/AN/A
#3
$32.1M2072%N/AN/A
#4
$10.1M65-16%N/AN/A
#5
$4.3M28-35%N/AN/A
#6
$21.4M13820%N/AN/A
#7
$22.6M146-15%N/AN/A
#8
$11.2M726%N/AN/A
#9
$8.1M52-26%N/AN/A
#10
$4M2613%N/AN/A
Add Company

What Is Olink Proteomics?

Through our dedication to innovation, quality, rigor and transparency, Swedish company Olink Proteomics provides outstanding products and services for human protein biomarker research. We help scientists get answers quickly and confidently through robust, multiplex biomarker analysis. Olink's immunoassay panels enable rapid, high-throughput analysis, with exceptional data quality and minimal sample consumption. Using just 1 µl of sample, 92 biomarkers are assayed simultaneously, with up to 96 samples run per panel. Our Proximity Extension Assay (PEA) technology enables this high level of multiplexing, as this dual recognition, DNA-coupled method provides exceptional readout specificity. Disease area-focused panels have both validated and exploratory biomarkers, selected in collaboration with leading experts, and our rigorous assay validation data is freely available. Choosing either ready-to-use kits or our Olink Analysis Service, customers get high quality data and rapid high-throughput analysis that makes the most effective use of their precious samples. In June 2016 Olink Proteomics opened a new office and laboratory facilities in Watertown, Massachusetts. This heralds the establishment of the company's first major regional organization outside of Sweden, and will support the rapidly growing business in the United States. For more information please visit www.olink.com.

keywords:N/A

N/A

Total Funding

797

Number of Employees

$123.5M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Olink Proteomics News

2022-04-19 - Olink to report first quarter 2022 financial results on May 12 ...

UPPSALA, Sweden, April 21, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB ... is a company dedicated to accelerating proteomics together with the...

2022-04-17 - High Multiplex Proteomics Using a Proximity Extension Assay with an Automated Liquid Handling System, Upc

Attendees will learn how Olink® Explore harnesses the power of next-generation sequencing (NGS) to enable high multiplex proteomics.

2019-03-12 - Summa Equity Acquires Olink Proteomics

"The scientific and business opportunities for Olink Proteomics are enormous, as its technology is radically transforming the market for ...

2018-11-06 - Olink Earns Acclaim from Frost & Sullivan for its Cardiac ...

"Responding to the market's lack of biomarkers able to provide the high-level granularity needed for precision medicine, Olink Proteomics ...

2016-04-12 - Olink Reorganizes, Splits Into Two Companies

Olink Proteomics will continue to expand and develop the Proseek Multiplex human protein biomarker discovery product portfolio and is aiming ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$311.1M105838%N/A
#2
$311M153210%N/A
#3
$1377.7M70294%N/A